Articles about 'NHS Blood and Transplant (NHSBT)'

A 3d animation of the COVID-19 Virus or Coronavirus being broken apart

‘Programmable molecular scissors’ could help fight COVID-19 infection

16 November 2022

Cambridge scientists have used synthetic biology to create artificial enzymes programmed to target the genetic code of SARS-CoV-2 and destroy the virus, an approach that could be used to develop a new generation of antiviral drugs.

Cell culture flasks in the incubator during manufacture of red blood cells

First ever clinical trial of lab-grown red blood cell transfusion

07 November 2022

Cambridge researchers are taking part in the world’s first clinical trial of red blood cells that have been grown in a laboratory for transfusion into another person.

Creative rendition of SARS-COV-2 virus particles

Remdesivir likely to be highly effective antiviral against SARS-CoV-2 for some patients

14 December 2020

̽��ֱ��drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists. Writing in Nature Communications, the researchers describe giving the drug to a patient with COVID-19 and a rare immune disorder, and observing a dramatic improvement in his symptoms and the disappearance of the virus.

Scientists create ‘genetic atlas’ of proteins in human blood

06 June 2018

An international team of researchers led by scientists at the ̽��ֱ�� of Cambridge and MSD has created the first detailed genetic map of human proteins, the key building blocks of biology. These discoveries promise to enhance our understanding of a wide range of diseases and aid development of new drugs.

̽��ֱ��